Search

everythinglearnresearchcommunity

for

Search:↓

Targeting specific genes in certain pathways may help treat male pattern baldness.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Blocking certain immune signals can reduce skin damage from radiation therapy.

The symposium highlighted the importance of genetics in understanding and treating complex skin diseases.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Type I interferons play a key role in the development of various skin diseases.

Activins and follistatins, part of the TGFβ family, are crucial for hair follicle development and skin health, affecting growth, repair, and the hair cycle.

Topical treatments led to hair regrowth in a man with linear morphea.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Apple extract called procyanidin B-2 was found to greatly increase hair growth.

PI3K/Akt pathway is crucial for hair growth and regeneration.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Finasteride helps hair growth by decreasing cell death in hair follicles.

Finasteride affects hair growth by changing caspase and XIAP levels, potentially treating hair diseases.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.